CNBC October 1, 2020
Christina Farr

Key Points

– Hims is a direct-to-consumer company selling health products and services targeted at millennials.

– The company, which operates both men’s and women’s brands and is sometimes called Hims & Hers, will raise $280 million through a merger with a SPAC sponsored by Oaktree Capital Management.

– Once the transaction is completed, the company will be traded on NYSE under the symbol “HIMS.”

Hims, Inc., a direct-to-consumer company that sells health products and services targeted at millennials, is going public just three years after it got its start.

The company, which operates both men’s and women’s health brands and is sometimes called Hims & Hers, is merging with a special purpose acquisition company (SPAC) sponsored by investment...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Health IT, Investments, Patient / Consumer, Technology, Telehealth, Trends
IPO Market Struggles as Investors Flock to AI
It's 'liquidity, stupid': VCs say tech investing is tough amid IPO lull and 'nuts' AI hype
Medeloop Raises $15.5M for AI-Driven Medical Research Platform
Healthcare & Life Sciences Private Equity Deal Tracker: Vance Street Invests in Prince Sterilization Services
Pharos Announces $5M Seed Round To Automate Hospital Quality Reporting

Share This Article